Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timonen

Showing results (771-780 of 796) with videos related to

Pageof 80
Sort By:
Nature Communications|March 10, 2026
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progressionLinus Wahnschaffe, Dennis Jungherz, Tony A Müller, et al.
Environmental Research|December 11, 2020
A call for urgent action to safeguard our planet and our health in line with the helsinki declarationJaana I Halonen, Marina Erhola, Eeva Furman, et al.
Environment International|September 27, 2023
Particle lung deposited surface area (LDSA<sup>al</sup>) size distributions in different urban environments and geographical regions: Towards understanding of the PM<sub>2.5</sub> dose-responseTeemu Lepistö, Henna Lintusaari, Anna Oudin, et al.
Cancer Research|October 30, 2025
Multi-omics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic DiscoveryAleksandr Ianevski, Kristen Nader, Julia Nguyen, et al.
BMJ Medicine|March 20, 2023
The interplay between inflammatory cytokines and cardiometabolic disease: bi-directional mendelian randomisation studyVille Karhunen, Dipender Gill, Jian Huang, et al.
Journal of Medicinal Chemistry|June 8, 2021
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic LeukemiaKrimo Toutah, Nabanita Nawar, Sanna Timonen, et al.
Blood|June 28, 2024
Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responsesJana von Jan, Sanna Timonen, Till Braun, et al.
Hemasphere|December 2, 2024
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphomaDaniel Pölöske, Helena Sorger, Anna Schönbichler, et al.
Environment International|May 25, 2019
Ultrafine particles and PM<sub>2.5</sub> in the air of cities around the world: Are they representative of each other?Alma Lorelei de Jesus, Md Mahmudur Rahman, Mandana Mazaheri, et al.
BMC Pregnancy and Childbirth|January 13, 2021
A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trialWilliam M Hague, Leonie Callaway, Jennifer Chambers, et al.
Pageof 80

Showing results (771-780 of 796) with videos related to

Sort By:
Pageof 80
Nature Communications|March 10, 2026
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progressionLinus Wahnschaffe, Dennis Jungherz, Tony A Müller, et al.
Environmental Research|December 11, 2020
A call for urgent action to safeguard our planet and our health in line with the helsinki declarationJaana I Halonen, Marina Erhola, Eeva Furman, et al.
Environment International|September 27, 2023
Particle lung deposited surface area (LDSA<sup>al</sup>) size distributions in different urban environments and geographical regions: Towards understanding of the PM<sub>2.5</sub> dose-responseTeemu Lepistö, Henna Lintusaari, Anna Oudin, et al.
Cancer Research|October 30, 2025
Multi-omics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic DiscoveryAleksandr Ianevski, Kristen Nader, Julia Nguyen, et al.
BMJ Medicine|March 20, 2023
The interplay between inflammatory cytokines and cardiometabolic disease: bi-directional mendelian randomisation studyVille Karhunen, Dipender Gill, Jian Huang, et al.
Journal of Medicinal Chemistry|June 8, 2021
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic LeukemiaKrimo Toutah, Nabanita Nawar, Sanna Timonen, et al.
Blood|June 28, 2024
Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responsesJana von Jan, Sanna Timonen, Till Braun, et al.
Hemasphere|December 2, 2024
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphomaDaniel Pölöske, Helena Sorger, Anna Schönbichler, et al.
Environment International|May 25, 2019
Ultrafine particles and PM<sub>2.5</sub> in the air of cities around the world: Are they representative of each other?Alma Lorelei de Jesus, Md Mahmudur Rahman, Mandana Mazaheri, et al.
BMC Pregnancy and Childbirth|January 13, 2021
A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trialWilliam M Hague, Leonie Callaway, Jennifer Chambers, et al.
Pageof 80